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Abstract
Liver regeneration (LR) after partial hepatectomy (PH) involves the proliferation and apoptosis of hepatocytes, and
microRNAs have been shown to post-transcriptionally regulate genes involved in the regulation of these processes. To
explore the role of miR-127 during LR, the expression patterns of miR-127 and its related proteins were investigated. MiR-
127 was introduced into a rat liver cell line to examine its effects on the potential target genes Bcl6 and Setd8, and
functional studies were undertaken. We discovered that miR-127 was down-regulated and inversely correlated with the
expression of Bcl6 and Setd8 at 24 hours after PH, a time at which hypermethylation of the promoter region of the miR-127
gene was detected. Furthermore, in BRL-3A rat liver cells, we observed that overexpression of miR-127 significantly
suppressed cell growth and directly inhibited the expression of Bcl6 and Setd8. The results suggest that down-regulation of
miR-127 may be due to the rapid methylation of its promoter during the first 24 h after PH, and this event facilitates
hepatocyte proliferation by releasing Bcl6 and Setd8. These findings support a miRNA-mediated negative regulation pattern
in LR and implicate an anti-proliferative role for miR-127 in liver cells.
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Introduction
As a developed organ with tremendous potential for re-
generation, the rat liver can grow back to its original mass and
function within 7–10 days after a 70% partial hepatectomy (PH).
Normally quiescent adult hepatocytes quickly enter and progress
through the cell cycle in a highly synchronized manner, and these
processes are automatically terminated after the liver mass is
restored [1]. Despite a significant studies that have addressed the
regulatory network of liver regeneration (LR) induced by PH (see
[2,3,4] for review), many aspects of this regulatory mechanism are
incompletely understood. In particular, the cellular and molecular
events that regulate the early stage of LR still must be defined, and
the identification of unknown markers (such as noncoding RNAs)
may lend insight into the post-PH regeneration process.
MicroRNAs (miRNAs) are a group of endogenous, small,
noncoding RNAs that have been shown to post-transcriptionally
regulate genes by binding to the 39-untranslated regions (UTRs) of
messenger RNA (mRNA). MiRNAs have been reported to
modulate a variety of biological processes, including cell differen-
tiation and proliferation, development, metabolic regulation and
apoptosis [5,6,7]. Recently, various studies have suggested that
miRNAs may play an important part in LR. For example, up-
regulated miR-21 was reported to be involved in regulating the
proliferative phase of LR by targeting Pellino-1 (Peli1) [8] and B-
cell translocation gene 2 (Btg2) [9], Down-regulated miR-378 has
a regulatory role by inhibiting DNA-synthesis-promoting gene
ornithine decarboxylase (Odc1) during the early phase of LR [9].
MiR-34a is up-regulated and contributes to the suppression of
hepatocyte proliferation by inhibiting inhibin bB( Inhbb) and Met as
described in our previous studies [10]. Especially, it has been
reported that 70% of miRNAs were down-regulated 24 hours (h)
after PH by a genomewide miRNA microarray study [11].
Considering the general down-regulation of miRNAs in human
cancers [12,13] and that pre-stage of hepatocellular carcinoma
(HCC) shares some resemblance with LR by a transcriptional
microarray analysis [14], we hypothesised that the down-
regulation of miRNAs in the early stage may have critical roles
in the synchronized process of LR, although these miRNAs must
still be illustrated.
In a preliminary study we found that miR-127 was down-
regulated 3 h after PH using a microarray analysis, and was
especially prominent at 24 h by a quantitative real-time PCR
(qRT-PCR) analysis. MiR-127 is typically expressed as part of
a miRNA cluster in normal cells, but not in cancer cells, and this
miRNA has a tumor-repressive function by targeting the pro-
oncogene B-cell lymphoma 6 protein (Bcl6) in T24 and Ramos
cells [15]. Previous studies also inferred that miR-127 has
a negative effect on clonogenic survival in irradiated human
endothelial cells [16]. More importantly, miR-127 is down-
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diet [17]. To further illuminate the roles of miR-127 in livers, the
present work sought to elucidate whether and how miR-127 and
its possible target genes are involved in LR by focusing on the first
24 h after PH. Our data suggest that the down-regulation of miR-
127 might contribute to the proliferation of hepatocytes by
targeting SET domain-containing protein 8 (Setd8) and Bcl6 during
the first 24 h after PH.
Results
MiR-127 Is Significantly Down-regulated and Inversely
Correlates with the Expression of Bcl6 and Setd8 during
the First 24 h after PH
To determine the miRNA expression pattern in the early phase
of LR, we performed a comprehensive miRNA expression
profiling analysis 3 h after PH or sham operation (SH)
(Figure 1A). Among these miRNAs, we identified 4 up-regulated
and 3 down-regulated rat miRNAs, in which miR-127 had at least
3-fold difference in expression between PH and SH (Figure 1B).
We then examined the expression levels of miR-127 during the
whole process of LR by qRT-PCR and found that miR-127 was
down-regulated at the early stage and was especially prominent at
24 h after PH, when miR-127 expression displayed an almost 4-
fold reduction compared to the SH group. In contrast, miR-127
was up-regulated at the late stage (120 h), in which miR-127
exhibited a 2-fold difference in expression between PH and SH
groups (Figure 1C). To further investigate the role of miR-127, we
measured the expression levels of miR-127 in rat liver tissues,
primary hepatocytes, BRL-3A and Huh7 cells. Results show that
the expression levels of miR-127 in rat liver tissues, rat primary
hepatocytes and BRL-3A cells were relatively higher than that in
human Huh7 hepatocarcinoma cells, and there were no significant
difference among rat liver tissues, primary hepatocytes and BRL-
3A cells (Figure 1D).
To determine how miR-127 participates in the regulation of
LR, we sought to identify miR-127 target genes during LR.
Bioinformatic tools for putative miR-127 target genes (TargetS-
can, miRanda and Pictar algorithms) were used. We selected 24
putative miR-127 target genes that could be involved in regulation
of biological or cellular processes as assigned by the pathway
classification analysis of these genes (Table S1) (Molecular
Annotation System, MAS, http://bioinfo.capitalbio.com/mas).
Furthermore, by qRT-PCR and Western blot analysis, we
observed a significant up-regulation of Bcl6 and Setd8 on both
the mRNA and protein levels in liver tissues 24 h after PH, a time
at which miR-127 is maximally decreased (Figure 2, A and B).
Over 24 h after PH, the expression of Bcl6 decreased and was
maintained at a relatively lower level until the late stage of LR. In
contrast, a biphasic induction of the histone H4 monomethylase
Setd8 was observed. The first peak occurred at 24 h after PH, and
a subsequent peak in expression occurred at 120 h. Setd8
expression returned to almost pre-resection levels by 168 h
(Figure 2B). Meanwhile, the SH group showed no significant
alteration in expression (data not shown). These data indicated an
inverse correlation between the putative target genes Bcl6, Setd8,
and miR-127 expression on both mRNA and protein levels during
the first 24 h after PH.
MiR-127 Modulates Rat Liver Cell Growth
To evaluate the effect of miR-127 in regulating rat liver cell
growth, BRL-3A immortalized rat liver cells were transfected with
miR-127 mimics or a negative control (NC) to up-regulate miR-
127 expression levels in liver cells. A cell cycle analysis and
a methylthiazol tetrazolium (MTT) cell proliferation assay were
employed. As shown in Figure 3A, the percentage of G2/M phase
cells in miR-127 and miRNA NC groups was (23.3260.37)% and
(17.6561.28)%, respectively, and the percentage of S phase cells
was (34.0060.24)% and (38.4760.84)%, respectively, indicating
that a subpopulation of cells is arrested in the G2/M phase by
transfection with miR-127 mimics. In addition, miR-127 mark-
edly reduced BRL-3A cell growth at 72 h (P,0.01), 96 h (P,0.05)
and 120 h (P,0.01), while miR-127 inhibitor promoted BRL-3A
cell growth at 96 h (P,0.01) and 120 h (P,0.01) compared with
the NC groups (Figure 3B) by the MTT cell proliferation analysis.
Our results suggest that miR-127 may have a negative regulatory
effect on the cell growth of rat liver cells.
MiR-127 Down-regulates Bcl6 and Setd8 Expression
To address the regulation of cell growth mediated by miR-127,
we examined the expression of the candidate target genes Bcl6 and
Setd8 in BRL-3A cells after treatment with miR-127 mimics, and
found that the expression of these genes were reduced after
treatment with miR-127 mimics compared to NCs at both the
mRNA and protein levels (Figure 4A). In order to verify whether
this down-regulation was only occurred in rat liver cells and
explore the potential significance of miR-127 in human liver
disease, HCC cell line, Huh7 cells were treated by the same way,
and the expression of these target genes was examined. As shown
in Figure 4B, treatment with miR-127 mimics caused significant
down-regulation of Bcl6 and Setd8 at both the mRNA and protein
levels.
To confirm that the inverse relationship of miR-127 expression
and that of its predicted target Setd8 is mediated by the 39-UTR,
we first determined the 39-end of the full-length Setd8 transcript by
39 rapid amplification of cDNA ends (RACE) (GenBank accession
JN896763). The 39-end of the Setd8 mRNA indeed included
a ‘‘seed sequence’’, and multiple alignments of the sequences of 39-
UTRs revealed higher sequence similarity among rat, mouse and
human (Figure 4C). We then fused the 39-UTR region of Setd8 to
a luciferase reporter to validate the effects of miR-127 mimics on
the wild-type and mutant plasmids. As shown in Figure 4D, miR-
127 markedly repressed the expression of the luciferase construct
that contained the original miR-127 binding site (Setd8 UTR), but
not the mutant binding site (Setd8 Mu-UTR). These results suggest
that Setd8 is a direct target gene of miR-127 in BRL-3A cells.
Down-regulation of MiR-127 may Participate in Cell
Growth Regulation through Bcl6 and Setd8 during LR
As a transcriptional repressor, Bcl6 mediates cell survival,
proliferation and differentiation by down-regulating over 500
direct target genes, such as p53, ATR, CHEK1 and CDKN1A,
during lymphomagenesis [18,19,20]. Among these direct targets,
we observed that CDKN1A was markedly induced after trans-
fection with Bcl6 siRNA at both the mRNA and protein levels, but
the expression of p53 was not statistically altered (Figure 5A). This
result indicated that CDKN1A might be a target of Bcl6, but not
p53 in BRL-3A cells. To confirm that the suppression of cell
proliferation by miR-127 was mediated by Bcl6, we assessed the
effect of Bcl6 siRNA on hepatocyte proliferation. Results show
that Bcl6 siRNA strongly repressed BRL-3A cell proliferation at
72 h (P,0.05), 96 h (P,0.01) and 120 h (P,0.01) (Figure 5B).
Additionally, because Setd8 has a role in cell cycle regulation by
monomethylating histone H4 on Lys20 (H4-K20me1) [21,22], we
measured the expression levels of H4-K20me1 and histone H4 in
BRL-3A cells treated with miR-127 mimics or miRNA NC.
Results show the transfection of miR-127 mimics notably reduced
H4-K20me1 expression but had no effect on histone H4
MiR-127 Suppression Facilitates Liver Regeneration
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LR was mediated by H4-K20me1, the expression pattern of H4-
K20me1 was determined by Western blotting. As shown in
Figure 5D, H4-K20me1 was maximally up-regulated at 24 h after
PH, and then decreased gradually, its expression was almost below
the levels in normal liver tissues at 168 h after PH. These data
indicate that miR-127 may regulate the progression of LR via the
monomethylating modification of histone H4 mediated by Setd8.
Together with the observation that compared with the SH group,
the PH group showed an increased proliferative activity at 24 h
after liver section (Figure 5E), we speculate that down-regulation of
miR-127 may participate in cell growth regulation through Bcl6
and Setd8 during LR.
MiR-127 Is Down-regulated by Hypermethylation of
a CpG Island in the Promoter Region 24 h after PH
MiR-127 is embedded in a CpG island, as determined by the
CpG Island Searcher Program (http://cpgislands.usc.edu/; Takai
and Jones, 2002) (Figure 6A). To explore a model of miR-127
regulation in rat liver during LR, we first analyzed miR-127
expression levels in BRL-3A cells treated with 5-aza-29-deoxycy-
tidine (5-Aza-CdR) and 4-phenylbutyric acid (PBA), which inhibit
DNA methylation and histone deacetylase, respectively. As shown
in Figure 6B, miR-127 was up-regulated 13-fold after the
combination treatment with 5-Aza-CdR and PBA but showed
no significant difference with either one of the two drugs alone,
indicating that miR-127 can be regulated by the synergistic effects
of DNA demethylation and the inhibition of histone deacetylase.
To assess whether miR-127 expression is regulated by the
methylation of its promoter region during the first 24 h after
PH, we measured the DNA methylation levels of the promoter
region of miR-127 by bisulfite sequencing. The results show that
the DNA methylation level of the CpG island was increased in the
PH group comparison to the SH group (mean of 86.3% versus
51.3%, P,0.01, Wilcoxon rank-sum test; Figure 6C). These
findings suggest that the down-regulation of miR-127 in rat liver
during the first 24 h of LR could be mediated by the DNA
hypermethylation of its promoter.
Discussion
LR after PH offers a unique and robust model to study the
initiation, progression, and termination of tissue growth in vivo
[23]. Although several studies addressed the mechanism by which
Figure 1. MiR-127 was prominently down-regulated at 24 h after partial hepatectomy (PH).( A) Scatter plot of miRNA expression in PH
rats versus SH rats at 3 h post surgery quantified by miRNA microarray which contains 988 human, 627 mouse, and 350 rat miRNA probes. (B) Seven
differentially expressed rat miRNAs were identified and ratio values .1.5 or ,0.7 were considered up-regulated (red) or down-regulated (green) in PH
rats compared to SH rats. MiR-127 was identified with at least 3-fold differences between the two groups. (C) The relative expression of miR-127
during liver regeneration by qRT-PCR analysis. (D) MiR-127 expression levels in rat liver tissues, primary hepatocytes, BRL-3A and Huh7 cells by qRT-
PCR analysis. MiR-127 levels were normalized to that of U6. Data from three independent experiments are shown as the means 6 SD. (*P,0.05,
**P,0.01).
doi:10.1371/journal.pone.0039151.g001
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rapid response mechanism of the remnant liver to PH. In
particular, little is known about the roles of miRNAs in promoting
the growth of the remaining livers. Using a rat model of small size
graft liver transplantation and a model of 50% hepatectomy,
previous studies have found that most miRNAs were down-
regulated in the liver grafts and the remaining livers and suggested
that down-regulated miRNAs play a pivotal role in promoting the
growth of the grafts and the remaining livers [24]. In the present
study, we identified several differentially expressed miRNAs by
microarray. Then we confirmed that miR-127 is strongly down-
regulated and inversely correlates with the expression of the target
genes Bcl6 and Setd8 during the first 24 h of LR, while the rebound
of miR-127 at 120 h post-PH suggests an inhibitory role of miR-
127 in the terminal phase. Our study also found that the artificial
down-regulation of miR-127 promotes cell proliferation, while up-
regulating miR-127 inhibits proliferation in rat liver cells
(Figure 3B), which could be partially attributable to G2/M
blockage (Figure 3A). Furthermore, cell growth assays in Huh7
cells also indicate that down-regulation of miR-127 may play
a proliferation-promoting role in human hepatocarcinoma cells
(Figure S1). Together with the observation that compared with the
SH group, the PH group showed an increased proliferative activity
at 24 h after liver section (Figure 5E). We proposed that the down-
regulation of miR-127 may contribute to the initiation of LR and
cell cycle progression during the first 24 h after PH, which is
characterised by enhanced proliferation.
To further investigate the specific role of miR-127 during LR, it
is very important to identify miR-127 target genes. Although
several lines of evidence suggest that transcription factors and cell
cycle control kinases have a critical role in initiating and
enhancing cell passage from G0 to G1 and in proliferation [25],
evidence is still required regarding the complicated regulation of
these processes during LR. Therefore, we used a Molecular
Annotation System to categorise all of the putative target genes of
miR-127 that were predicted by the Targetscan, miRanda and
Pictar algorithms. Interestingly, we identified Bcl6 and Setd8, which
may participate in cell proliferation and cell cycle control, as direct
target genes in rat liver cells. As a proto-oncogene, Bcl6 can be
repressed by p53 through a p53 response element (p53RE), and
a p53-Bcl6 autoregulatory loop may exist [26]. In our study, we
found that an inverse correlation between Bcl6 and miR-127
expression on both mRNA and protein levels during the first 24 h
after surgery. Further studies found that CDKN1A was induced
when Bcl6 was down-regulated in rat liver cells, suggesting that the
miR-127-Bcl6 signaling may regulate the expression of CDKN1A
during LR. However, according to previous reports, CDKN1A
was highly induced 24h after PH and can be regulated by p53-
dependent and -independent pathways in the liver [27]. In
addition, the CDKN1A promoter also contains p53 binding sites,
and its transcription can be induced by p53 [28], which is highly
induced during the prereplicative stage of LR [29,30]. Therefore,
it seems to infer that up-regulation of Bcl6 at 24 h after PH may
contribute in part to antagonize the p53-mediated induction of
CDKN1A. And an in vivo study of miR-127 in rat LR model will
be helpful to elucidate the exact mechanisms that govern the
expression of CDKN1A. On the other hand, p53 expression was
not altered in BRL-3A cells after repression of Bcl6 (Figure 5A)
while it was induced in Huh7 cells (Figure S2). This result suggests
that the p53-Bcl6 autoregulatory loop does not function in rat liver
cells, which is consistent with previous findings that the p53-Bcl6
loop may exist only in primates because of evolutionary race
conservation [26]. Together with the observation that Bcl6 siRNA
reduced proliferation in BRL-3A cells (Figure 5B), we presumed
that the repression of miR-127 may contribute to the regulation of
liver cell proliferation via a Bcl6-mediated antagonism to the p53-
mediated induction of CDKN1A during the first 24 h of LR.
Another target of miR-127 that we firstly identified in rat liver
cells, Setd8, is a member of a family of histone lysine
methyltransferases and can monomethylate histone H4 on
Lys20. Setd8 protein levels and histone H4 Lys20 methylation
are cell cycle-regulated [21,22]. The inhibition of Setd8 using
shRNA results in the arrest of replication forks, the induction of
double-stranded DNA breaks and Chk1-mediated cell-cycle arrest
in the S and G2/M phases of the cell cycle [31,32]. In this study,
Setd8 demonstrated a high induction between 24 h and 120 h
after PH, while the catalysate of Setd8, H4-K20me1, showed
Figure 2. MiR-127 expression inversely correlates with the
expression of Bcl6 and Setd8 during liver regeneration. (A) The
mRNA expression of Bcl6 and Setd8 were analyzed by qRT-PCR. b-actin
was used as the internal control. Data from three independent
experiments are shown as the means 6 SD. (B) The protein expression
of Bcl6 and Setd8 were analyzed by Western blotting. The quantifica-
tion of bands of Bcl6 and Setd8 were performed by densitometry. Actin
was used as a control. Representative data from one of three
independent experiments are shown.
doi:10.1371/journal.pone.0039151.g002
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LR (Figure 5D). It may imply that H4-K20me1 at the terminal
stage of LR might be further di-methylated and/or tri-methylated
by other histone H4 methyltransferases such as SUV420H1,
SUV420H2 and NSD2. Considering that Setd8 can also modulate
the functions of p53 by the methylation of lysine 382 [33], and p53
has been proposed to be expressed at a higher level in rats
receiving PH than in the SH group [30]. We speculate that Setd8
might involve in the p53-mediated transcriptional regulation in the
terminal stage of LR. Setd8 up-regulation in the late stage of LR
implies that there may exist other regulation models besides miR-
127, such as the Ser-29 phosphorylation of Setd8 mediated by the
Cdk1/cyclinB complex, which may stabilize Setd8 by inhibiting
anaphase-promoting complex (APC)-mediated ubiquitination and
proteasome-mediated degradation of Setd8 [34], and it must be
further studied. Together with that the H4-K20me1 (Figure 5C)
and Setd8 levels (Figure 4A) decreased markedly in the miR-127-
treated rat liver cells compared to the control group. We suggest
a possible epigenetic mechanism in the regulation of LR that
consists of the miR-127-mediated up-regulation of Setd8 during
the first 24 h of LR.
Figure 3. MiR-127 modulates rat liver cell growth. (A) Cell cycle of BRL-3A cells transfected with miR-127 mimics (miR-127) or miRNA negative
control (miRNA NC) were analyzed by flow cytometry. (B) Proliferation of BRL-3A cells transfected with either miR-127 mimics (green), miR-127
inhibitor (red), miRNA NC (blue) or inhibitor NC (yellow) was examined at the indicated time by methylthiazol tetrazolium. Data from three
independent experiments are shown as the means 6 SD. (*P,0.05, **P,0.01).
doi:10.1371/journal.pone.0039151.g003
Figure 4. MiR-127 down-regulates Bcl6 and Setd8 expression. (A and B) BRL-3A (A) and Huh7 (B) cells transfected with miR-127 mimics or
miRNA NC were analyzed by qRT-PCR (left) and Western blotting (right), respectively. Actin was used as a control. (C) Graphic overview of the
conserved 39UTR sequences of Setd8 among rat, mouse and human. The ‘‘seed sequences’’ in the 39UTRs of Setd8 mRNA were indicated (red box).
(D) The repression of Setd8 gene mediated by the 39-UTR was analyzed by luciferase reporter assay. BRL-3A cells were cotransfected with a luciferase
reporter vector containing the 39-UTR or the mutated 39-UTR (Mu-UTR) of Setd8 and miR-127 mimics (miR-127) or the negative control (NC). The
pGL4.13 control vector was used as a control. The wild-type and mutated miR-127-binding sites in the 39-UTR of this gene were indicated (left). Data
from three independent experiments are shown as the means 6 SD. (*P,0.05, **P,0.01).
doi:10.1371/journal.pone.0039151.g004
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transcribed in an antisense orientation to a retrotransposon-like
gene (Rtl1) [35], and the expression of miR-127 has been shown to
undergo DNA methylation regulation in mouse embryos [36] and
human cancer cells [15]. To elucidate the activation mechanism of
miR-127 in LR, we analyzed the promoter region of the miR-127
gene in rats and found a CpG island in it, further studies show that
the CpG island was highly methylated 24 h after PH by bisulfite
genomic sequencing. These results indicate that the down-
regulation of miR-127 after PH may be due to the rapid
methylation of the promoter of the miR-127 gene. This conclusion
is further supported by the highly induced expression of miR-127
following treatment with 5-Aza-CdR and PBA, which inhibit
DNA methylation and histone deacetylase, respectively. Although
a recent study showed that promoter of miR-127 was activated by
estrogen related receptor gamma (ERRc) and inhibited by small
heterodimer partner (SHP) [37], further researches will be
required to determine whether miR-127 is regulated by ERRc
and SHP in rat LR.
In conclusion, miR-127 is down-regulated within the first 24 h
after PH due to the rapid methylation of its promoter, and this
event facilitates hepatocyte proliferation by releasing Bcl6 and
Setd8. Our findings reveal a miRNA-mediated negative regulation
pattern that occurs during the first 24 h of LR and suggest an anti-
proliferative role for miR-127 in liver cells.
Figure 5. Down-regulation of miR-127 may participate in cell growth regulation through Bcl6 and Setd8 during the first 24 h after
PH. (A) CDKN1A, but not p53, is a downstream target gene of Bcl6. BRL-3A cells were transfected with Bcl6 siRNA or a negative control (siRNA NC),
and the relative expression levels of mRNA (left) and protein (right) were analyzed by qRT-PCR and Western blotting, respectively. Actin was used as
a loading control. (B) Down-regulation of Bcl6 suppresses hepatocyte proliferation. BRL-3A cells were transfected with Bcl6 siRNA or siRNA NC, and
the relative cell proliferation was examined at the indicated time by methylthiazol tetrazolium. (C) MiR-127 decreased the protein expression of
monomethyl histone H4. The protein expression of cells treated with miR-127 mimics or miRNA NC was analyzed by Western blotting. Actin was used
as a control. (D) The expression of monomethyl histone H4 during LR was analyzed by Western blotting. Actin was used as a control. (E) Liver sections
were stained with PCNA (4006magnification) from 3 to 72 h after PH. All the data were obtained from at least three independent experiments and
are shown as the means 6 SD. (*P,0.05, **P,0.01).
doi:10.1371/journal.pone.0039151.g005
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Ethics Statement
All animals were cared appropriately according to the In-
stitutional Animal Care Instructions approved by the Ethics
Committee for Animals of the Second Military Medical Univer-
sity. All experiments were performed in accordance with the
Institutional Animal Care Instructions approved by the Ethics
Committee for Animals of the Second Military Medical University
(Approval ID: SCXK 2007-0003).
Animals and Surgery
Adult male Sprague-Dawley rats (180–210 g) were randomly
assigned to PH and SH groups (25 animals in each group) and fed
standard laboratory chow ad libitum with free access to water. After
an overnight fast, rats were anaesthetized with sodium pentobar-
bital (30 mg/kg, intraperitoneally), and underwent PH by removal
of 70% of total liver mass (left lateral, left median, and right
median lobes) according to the method of Higgins and Anderson
[38]. For the sham operation (SH), rats underwent laparotomy
and liver manipulation under anaesthesia without tissue removal.
Rats were offered food and water ad libitum after the operation. At
the indicated time points (3, 24, 72, 120 or 168 h after surgery, 5
animals in each sub-group), the animals were euthanized, and the
remaining liver tissues were collected. Adult rat primary
hepatocytes were isolated and plated as described in detail
elsewhere [39].
Global MiRNA Expression Profiling
Liver samples were obtained at 3 h after surgery, total RNA
samples isolated by the Ambion miRNA Isolation Kit were used
for analysis of miRNA expression changes after 2/3 PH by
CapitalBio Corporation (CapitalBio, Beijing, China). MiRNA
expression profiling including labeling, hybridization, scanning,
normalization, and data analysis was performed at CapitalBio.
Fluoresce-in-labeled miRNAs were used for hybridization on each
miRNA microarray chip containing 1320 probes in triplicate,
corresponding to 988 human (including 122 predicted miRNAs),
627 mouse, and 350 rat miRNAs found in the miRNA Registry
(http://microrna.sanger.ac.uk/sequences/). The differential miR-
NAs were selected using the program Significance Analysis of
Microarrays (version 2.1). The alterations were defined as those
with either ,0.7- or . 1.5-fold changes and the d value ,0.05.
Figure 6. MiR-127 is induced from its promoter by DNA demethylation and histone deacetylase inhibition. (A) Schematic representation
of the CpG island on the promoter region of the miR-127 gene. (B) MiR-127 is highly induced by 5-Aza-CdR and PBA treatment. BRL-3A cells were
treated with 5-Aza-CdR and/or PBA, and the miR-127 expression level was analyzed by qRT-PCR. U6 RNA expression was used as a loading control.
0.1A, 0.1 mmol/L 5-Aza-CdR; 1A, 1 mmol/L 5-Aza-CdR; 3A, 3 mmol/L 5-Aza-CdR; 0.1P, 0.1 mmol/L PBA; 1P, 1 mmol/L PBA; 3P, 3 mmol/L PBA; 0.1AP,
combination of 0.1 mmol/L 5-Aza-CdR and 0.1 mmol/L PBA; 1AP, combination of 1 mmol/L 5-Aza-CdR and 1 mmol/L PBA; 3AP, combination of 3
mmol/L 5-Aza-CdR and 3 mmol/L PBA. Data from three independent experiments are shown as the means 6 SD. (**P,0.01). (C) The CpG island was
hypermethylated 24 h after partial hepatectomy (PH). Genomic DNA was obtained from rat liver tissues 24 h after PH or sham operation (SH), the
DNA methylation status was determined by bisulfite genomic sequencing (P,0.01, Wilcoxon rank-sum test).
doi:10.1371/journal.pone.0039151.g006
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An established rat liver cell line, BRL-3A (ATCC number:
CRL-1442) and a human hepatoma cell line, Huh-7, were
obtained from the Institute of Biochemistry and Cell Biology,
Shanghai, China. Cells were cultured in Dulbecco’s modified
Eagle’s medium (Gibco, BRL) with 10% fetal bovine serum (FBS;
Gibco, BRL) and were maintained in a humidified 37uC incubator
with an atmosphere of 5% CO2. MiR-127 mimics, miR-127
inhibitor, or their relative negative control RNAs, Bcl6 siRNA and
its negative control RNA were obtained from GenePharma
(Shanghai, China). Transfections were performed using a Lipofec-
tamine 2000 kit (Invitrogen, Carlsbad, CA) according to the
manufacturer’s instructions. Transfected cells were harvested at 24
or 48 h.
Reverse Transcription and Quantitative Real-time PCR
Total RNA was isolated from the prepared liver samples and
cells using TRIzol reagent (Invitrogen), and cDNA was synthe-
sized following the manufacturer’s protocols (MBI Fermentas).
qRT-PCR was performed with a standard SYBR-green PCR kit
(TOYOBO), and the gene-specific PCR amplification was
performed using the Applied Biosystems 7300 Sequence Detection
system (Applied Biosystems, USA), the qRT-PCR reactions were
performed in triplicate and included no-template controls.
Relative gene expression was calculated with the 2
2DDCt method
after normalization to the expression of b-actin or U6 small
nuclear RNA [40]. The primers are listed in Table 1.
To determine the 39-end of the full-length Setd8 transcript,
39RACE PCR was performed using a FirstChoice RLM-RACE
kit (Ambion, USA). The RACE experiments were performed
according to the instructions included in the kit. PCR products
were cloned into the TA cloning vector pMD18-T (Takara,
Dalian, China) and sequenced.
Cell Proliferation Assay by Methylthiazol Tetrazolium
Cells transfected with miR-127 mimics, miR-127 inhibitor, Bcl6
siRNA or the corresponding NCs in 6-well plates were re-seeded
onto 96-well plates at a density of 1000 cells per well 24 h after
transfection. At the indicated time points (24, 48, 72, 96, 120 h),
20 mL of a MTT solution (5 mg/mL) was added, and the cells
were incubated for 4 h. Subsequently, 150 mL dimethyl sulfoxide
(DMSO) was added to each well to dissolve the crystals. The
absorbance of each sample was recorded at 570 nm 10 minutes
(min) after the addition of DMSO.
Cell Cycle Analysis by Flow Cytometry
Cells were transfected with miR-127 mimics and the negative
control. After an additional incubation of 24 h, the cells were
harvested. For the cell cycle analysis, the cells were fixed with 75%
ethanol for 24 h and then washed with ice-cold phosphate-
buffered saline (PBS) containing 2% FBS. Cells were then spun
down, resuspended using RNase-containing (1:100 in dilution)
PBS on ice prior to staining with PI and analyzed using a flow
cytometer. Data acquisition and analysis were performed using
a FACSort Cytometer (FACS, CA, USA). For each analysis,
1610
5 cells were scanned. Each experiment was repeated at least
three times.
Luciferase Reporter Constructs, Site-directed
Mutagenesis and Luciferase Reporter Assay
The 39-UTR of Setd8, which contains the miR-127 response
element, was cloned into the pGL4.13 luciferase reporter vector
(Promega) between the XbaI and FseI restriction sites using
a directional RT-PCR cloning strategy. Mutant 39-UTR of Setd8
was synthesized by PCR. The primers are listed in Table 1. The
resulting luciferase reporter constructs, pGL-Setd8-UTR and pGL-
Set8-Mu-UTR, which contain the wild-type 39-UTR and the
mutant 39-UTR of Setd8, respectively, were sequenced to ensure
accuracy. BRL-3A cells were seeded in a 24-well plate (1610
5 per
well) and were transfected with 200 ng of the indicated luciferase
reporter constructs with miR-127 mimics or miRNA NC. Each
sample was cotransfected with 20 ng of the renilla luciferase
control vector pGL4.70 (Promega) to monitor transfection
efficiency. The pGL4.13 control vector was used as a control.
Forty-eight hours later, all protein extracts were analyzed using the
dual luciferase reporter assay system (Promega).
Western Blot Analysis
Tissues and cells were lysed in RIPA lysis buffer (Promega). The
lysates were sonicated and centrifuged at 12,000 rpm at 4uC for
10 min. Equal amounts of protein were separated using 10–15%
sodium dodecyl sulphate-polyacrylamide gel electrophoresis and
were transferred to nitrocellulose membranes (Amersham Phar-
macia, UK). For immunodetection, membranes were incubated
with specific antibodies (anti-CDKN1A, anti-Bcl6, anti-Setd8,
anti-histone H4, anti-monomethyl histone H4, anti-p53 (Santa
Cruz Biotechnology), and anti-actin (Sigma)). The immunoblots
were developed using horseradish peroxidase (HRP)-coupled anti-
mouse or anti-rabbit secondary antibodies (ProteinTech Group)
followed by detection with enhanced chemiluminescence (Pierce
Biotechnology). Actin was used as a control.
Immunohistochemical Analysis
The rat liver tissues were collected at the indicated time points
(3, 24 and 72 h) after a PH or SH, and fixed with formalin. The
fixed tissues were processed for paraffin embedding and serial
5 mm thick sections were prepared. Proliferating cell nuclear
antigen (PCNA) analysis was performed using the labelled
streptavidin biotin (LSAB) method. The slides were first incubated
with an anti-PCNA antibody (Cell Signaling Technology, MA,
USA) and then with a biotinylated secondary antibody (Chem-
Mate ENVISION). All stained sections were examined under
a light microscope at a 6400 magnification. The PCNA index
corresponds to the number of positively stained cells/total number
of cells counted in each section.
5-Aza-CdR and PBA Treatment
5-Aza-CdR (Sigma-Aldrich, St. Louis, MO) and PBA (Sigma-
Aldrich) were dissolved in PBS and DMSO at concentrations of
3 mmol/L and 3 mol/L, respectively. BRL-3A cells were seeded
at 2610
5 cells per well in 6-well plates 24 h prior to treatment with
5-Aza-CdR (0.1 mmol/L, 1 mmol/L or 3 mmol/L) and/or PBA
(0.1 mmol/L, 1 mmol/L or 3 mmol/L). 5-Aza-CdR was removed
after 24 h, while PBA was continuously administered by replacing
the medium containing PBA every 24 h for 5 days. DMSO-
treated cells were used as controls, and each experiment was
repeated at least three times.
DNA Extraction, Bisulfite Treatment and Genomic
Sequencing
Genomic DNA was extracted from liver tissues 24 h after PH
treatment with the Axygen genomic DNA purification kit (Axygen
Biotechnology). Genomic DNA (0.5 mg) was treated with sodium
bisulfite with the Zymo EZ DNA Methylation Gold kit (Zymo
Research) and then the Bisulfite-converted genomic DNA was
amplified with primers (Table 1.) to detect 2266 and +36 of the
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subcloned into pMD-18T vectors (Takara), and transformed into
Escherichia coli. Candidate plasmid clones were sequenced by
Invitrogen, Ltd.
Statistical Analysis
The bisulfite DNA sequencing results were compared using the
Wilcoxon rank-sum test. Other results were compared using
Student’s t test, and the data are expressed as the means and
standard deviations of at least three independent experiments. All
of the P values were two-tailed and were obtained with the SPSS
18.0 software package (SPSS, Chicago, IL). A P value ,0.05 was
considered statistically significant.
Supporting Information
Figure S1 Down-regulation of miR-127 promotes cell
proliferation in Huh7 cells. (A) MiR-127 inhibition increases
the percentage of S phase cells and reduces the percentage of G2/
M phase cells in Huh7 cells. Cell cycle of Huh7 cells transfected
with miR-127 inhibitor or inhibitor NC were analyzed by flow
cytometry. (B) MiR-127 inhibition promotes Huh7 cell pro-
liferation. Proliferation of Huh7 cells transfected with either miR-
127 inhibitor or inhibitor NC was examined at the indicated time
by methylthiazol tetrazolium. (C) Down-regulation of miR-127
induces the expression of Bcl6 and Setd8. Cells transfected with
miR-127 inhibitor or inhibitor NC were analyzed by qRT-PCR
(left) and Western blotting (right), respectively. Actin was used as
a control. Data from three independent experiments are shown as
the means 6 SD. (*P,0.05).
(TIF)
Figure S2 p53 is induced by silencing of Bcl6 in Huh7
cells. Huh7 cells were transfected with Bcl6 siRNA or a negative
control (siRNA NC), and the relative expression levels of mRNA
(left) and protein (right) were analyzed by qRT-PCR and Western
blotting, respectively. Actin was used as a loading control.
(*P,0.05).
(TIF)
Table S1 Candidate miR-127 target genes.
(XLSX)
Table 1. Primers Used in qRT-PCR and Vector Construction.
Primer Names Sequences (59. . 39)
miR-127 AGAGGCGGACGGTGTCGTAGTTGAAGTGAGCCGTCCGCCTCTAGCCAAGC
GATGTCGGATCCGTCTGAGC
CGGTGTCGTAGTTGAAGTGAG
U6 GTGCCTGCTTCGGCAGCACATA
TGGAACGCTTCACGAATTTGCGTGTC
b-Actin CACCCGCGAGTACAACCTTC
CCCATACCCACCATCACACC
Human-b-Actin TGATATCGCCGCGCTCGTCG
ACCCATGCCCACCATCACGC
Bcl6 TCGAGGTCGTGAGGTTGT
CGGATAAGAGGCTGGTGG
Human-Bcl6 GAGCCTTTGCCCCCAGCCTG
GGGGTTGGCCACAGGCATCC
Setd8 ATCACCGATGCCAAGAAGC
CGTCGATGTCATGCAGTTTG
Human-Setd8 GCAAACTTACGGATTTCTACCCT
CATTCCTTCTTCCTTCCCACTT
p53 CGGCTCCGACTATACCACTAT
GGACAGGCACAAACACGAA
Human-p53 GCTTTGAGGTGCGTGTTTGT
TTGGGCAGTGCTCGCTTAG
CDKN1A GCAAAGTATGCCGTCGTCT
CAAAGTTCCACCGTTCTCG
MSP* TTTTTGAGTTTTAGTAGGTTGG
ACCAAACRATACTCTCCATATA
Setd8 39-UTR GCTCTAGATAACCTGTGATAGCAAGAGTGGG
GATGGCCGGCCCCACAAACAGGTACAACCAAGAC
Setd8-Mu 39-UTR TCAGACTTGGAGGAGACGCAGACAGGAGGGTGTAAC
GTTACACCCTCCTGTCTGCGTCTCCTCCAAGTCTGA
*Primers used for bisulfite genomic sequencing.
doi:10.1371/journal.pone.0039151.t001
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